Unichem Laboratories would use at least half the net proceeds from sale of its domestic business to reward shareholders. And, use the rest for research & development (R&D) and to expand its international business, Chairman Prakash Mody has said.
“It could either be through a dividend or a share buyback or both. The promoters will not benefit at the cost of other shareholders. The board (of directors) is very clear about it,” Mody said, a day after he concluded a Rs 3,600-crore transaction to sell the domestic formulations business to Torrent Pharmaceuticals.
The seven decade-old Unichem is among the oldest

)